Daisuke Nishizaki, MD @zacksurg X Profile

Daisuke Nishizaki, MD

@zacksurg

Followers

26

Following

124

Media

1

Statuses

25

Surgical oncologist / Clinical research, precision medicine, data visualization, minimally invasive surgery / Tweets are my own

San Diego / Kyoto

Joined September 2019

Don't wanna be here? Send us removal request.

The Lancet Oncology

@TheLancetOncol

8 months

New research: Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for #oesophagealcancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial https://t.co/7pQ9KeJYnQ

0

31

63

Daisuke Nishizaki, MD

@zacksurg

1 year

https://t.co/DiM0QJwmwT

pubmed.ncbi.nlm.nih.gov

Compared to surgery alone, nCRT did not significantly improve RFS in the overall population but significantly improved RFS in mrEMVI-positive patients.

0

Daisuke Nishizaki, MD

@zacksurg

1 year

🔥Hot off the press🔥 from Kyoto. Neoadjuvant chemoradiotherapy is associated with better RFS among patients with positive mrEMVI. https://t.co/BK4OltkS94

1

0

Daisuke Nishizaki, MD

@zacksurg

1 year

🔥Hot off the press!! Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS Mutations | Journal of Clinical Oncology https://t.co/hJuEZZZ5ET

ascopubs.org

PURPOSEMucinous neoplasms of the gastrointestinal tract are characterized by a propensity for metastasis to the peritoneum, resulting in peritoneal mucinous carcinomatosis (PMC). A subset of these...

1

2

Yu Fujiwara, MD

@waraonc23

1 year

Good morning! Excited to present our research progress focusing on B- and T-cell factors and their response to immunotherapy. Poster #105 at Hall A from 9AM to noon today. @RoswellHemOnc @zacksurg @HirotakaMd @Labcorp @OmniSeq @Dr_R_Kurzrock #ASCO24 https://t.co/7BGLDoDFL3

ascopubs.org

2626Background: Maturation of lymphoid structures and tumor-antigen presentation via B cells in the tumor microenvironment (TME) have been recognized as factors in tumor immunity. The presence of B...

0

4

12

DCRjournal

@DCRjournal

2 years

What factors influence a patient returning to work after colorectal cancer surgery? Find out in this #DCRJournal digital exclusive report from Japan: https://t.co/y6rjZQnZor @JohnRTMonsonMD @jendavidsmd @ScottRSteeleMD @Swexner @me4_so @ACPGBI @drtracyhull @ASCRS_1

1

6

9

Yu Fujiwara, MD

@waraonc23

3 years

@ASCO abstract titles released! See you all in AM on June 3rd at the Poster hall @McCormick_Place in Chicago #ASCO23 I'll present our work (#2614) on associations of IDO1 with immune markers as well as it's impact on survival of immune checkpoint inhibitors. #PrecisionMedicine

0

2

6

Daisuke Nishizaki, MD

@zacksurg

3 years

Of Mice, Not Men: When the Bench-to-Bedside Bridge Is Broken

pmc.ncbi.nlm.nih.gov

0

1

Daisuke Nishizaki, MD

@zacksurg

4 years

Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor... https://t.co/DJM8a1TxzA via @JAMASurgery part of @JAMANetwork

0

Daisuke Nishizaki, MD

@zacksurg

4 years

Transanal total mesorectal excision and low anterior resection syndrome

academic.oup.com

In this population-based propensity-score matched study, TaTME was associated with higher rates of severe bowel dysfunction compared to LAR. Patients shoul

0

JCOG

@JCOG_official

4 years

🆕JCOG0603 "Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial" was published in JCO! https://t.co/ldSdpqST7T #ColorectalCancer #JCO @ASCO @ASCO_pubs #JCOG

8

52

98

Cochrane

@cochranecollab

4 years

It is with considerable regret that @cochranecollab's Governing Board announces the cancellation of Cochrane Colloquium Toronto which had been rescheduled for 11-14th September, 2022. https://t.co/ZQcw41Od8z @CochraneCanada

0

4

0

Daisuke Nishizaki, MD

@zacksurg

4 years

Do you remember, the 21st night of September? Tonight! Earth, Wind & Fire - September (Official HD Video) https://t.co/od4wJdzHDz

0

Daisuke Nishizaki, MD

@zacksurg

4 years

Simpson's Paradox https://t.co/6VzIjVoerV

0

Daisuke Nishizaki, MD

@zacksurg

5 years

HR is the mainstream, but RMST is easy to interpret. Would it be a new standard? Using the Restricted Mean Survival Time Difference as an Alternative to the Hazard Ratio for Analyzing Clinical Car…

pubmed.ncbi.nlm.nih.gov

Using the Restricted Mean Survival Time Difference as an Alternative to the Hazard Ratio for Analyzing Clinical Cardiovascular Studies

0

Daisuke Nishizaki, MD

@zacksurg

5 years

Interesting. Association of Daily Wear of Eyeglasses With Susceptibility to COVID-19 Infection

0

Daisuke Nishizaki, MD

@zacksurg

5 years

https://t.co/Z7Hghaajc6

0

1

Daisuke Nishizaki, MD

@zacksurg

5 years

Regression Discontinuity Study Design To Estimate Observational Differences

0

Daisuke Nishizaki, MD

@zacksurg

6 years

School Closure During the Coronavirus Disease 2019 (COVID-19) Pandemic

jamanetwork.com

This Viewpoint discusses the effectiveness of school closure as a preventive measure during the coronavirus disease 2019 (COVID-19) pandemic.

0

Cochrane

@cochranecollab

6 years

"With the deepest disappointment and regret I have to inform you that as a result of the continued spread and impact of the COVID-19 across the world, Cochrane’s 27th Colloquium in Toronto, Canada, between 4th-7th October this year has been cancelled."

1

28

26